{"id":"oseltamivir-iv","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Vomiting"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Neuropsychiatric events"}]},"_chembl":{"chemblId":"CHEMBL1229","moleculeType":"Small molecule","molecularWeight":"312.41"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Oseltamivir phosphate is converted to its active form and inhibits influenza neuraminidase, an enzyme on the viral surface required for budding and release of new viral particles from host cells. By blocking neuraminidase activity, the drug prevents viral dissemination and reduces the duration and severity of influenza infection. The IV formulation provides direct systemic delivery for patients unable to take oral medication.","oneSentence":"Oseltamivir is a neuraminidase inhibitor that blocks the release of influenza virus particles from infected cells, reducing viral spread.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:24:52.193Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of acute influenza infection in hospitalized patients"},{"name":"Prophylaxis of influenza in high-risk patients"}]},"trialDetails":[{"nctId":"NCT07306702","phase":"PHASE4","title":"Dexmedetomidine-Enhanced PCIA After Lobectomy in Nicotine-Dependent Patients","status":"COMPLETED","sponsor":"Shenyang Sixth People's Hospital","startDate":"2023-07-01","conditions":"Postoperative Pain Management","enrollment":102},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT03900988","phase":"PHASE3","title":"Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia","status":"UNKNOWN","sponsor":"Chinese University of Hong Kong","startDate":"2023-05-08","conditions":"Influenza","enrollment":160},{"nctId":"NCT03040141","phase":"PHASE2","title":"Study of Efficacy and Safety of IV VIS410 Plus Oseltamivir Versus Oseltamivir in Hospitalized Adults With Influenza A","status":"COMPLETED","sponsor":"Visterra, Inc.","startDate":"2018-01-03","conditions":"Influenza A","enrollment":89},{"nctId":"NCT04353180","phase":"PHASE3","title":"Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 ( Isotretinoin in Treatment of COVID-19) (Randomized)","status":"UNKNOWN","sponsor":"Kafrelsheikh University","startDate":"2021-08","conditions":"COVID19","enrollment":100000},{"nctId":"NCT02369159","phase":"PHASE3","title":"Safety, PK and Effectiveness of IV Peramivir Versus Oseltamivir in Pediatric Subjects With Uncomplicated Influenza","status":"COMPLETED","sponsor":"BioCryst Pharmaceuticals","startDate":"2015-03-11","conditions":"Influenza","enrollment":137},{"nctId":"NCT02927431","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2017-01-19","conditions":"Virus Diseases","enrollment":10},{"nctId":"NCT04361422","phase":"PHASE3","title":"Isotretinoin in Treatment of COVID-19","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2020-12-01","conditions":"COVID-19","enrollment":300},{"nctId":"NCT03903718","phase":"PHASE2","title":"Evaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat Influenza","status":"WITHDRAWN","sponsor":"MedImmune LLC","startDate":"2020-04-03","conditions":"Influenza","enrollment":""},{"nctId":"NCT04183725","phase":"PHASE4","title":"Clinical Study of Reduning Injection for the Treatment of Influenza in Children","status":"UNKNOWN","sponsor":"China Academy of Chinese Medical Sciences","startDate":"2019-12-01","conditions":"Influenza in Children","enrollment":240},{"nctId":"NCT02609399","phase":"PHASE4","title":"ED Influenza Therapeutic Pilot Study: Oseltamivir vs. Peramivir","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2015-11-01","conditions":"Influenza","enrollment":180},{"nctId":"NCT01231620","phase":"PHASE3","title":"A Study of Intravenous Zanamivir Versus Oral Oseltamivir in Adults and Adolescents Hospitalized With Influenza","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-01-15","conditions":"Influenza, Human","enrollment":626},{"nctId":"NCT02293863","phase":"PHASE2","title":"A Study of MHAA4549A in Combination With Oseltamivir Versus Oseltamivir in Participants With Severe Influenza A Infection","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2015-01-14","conditions":"Influenza","enrollment":168},{"nctId":"NCT02603952","phase":"PHASE1, PHASE2","title":"A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza","status":"COMPLETED","sponsor":"MedImmune LLC","startDate":"2015-12-07","conditions":"Influenza","enrollment":126},{"nctId":"NCT01980966","phase":"PHASE2","title":"A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2013-11-25","conditions":"Healthy Volunteer","enrollment":101},{"nctId":"NCT01249833","phase":"PHASE4","title":"Effect of Oseltamivir on Cognitive Function in Subjects With Influenza","status":"COMPLETED","sponsor":"Trial Management Group Inc.","startDate":"2010-11","conditions":"Influenza","enrollment":122},{"nctId":"NCT01050257","phase":"PHASE3","title":"A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2010-01","conditions":"Influenza","enrollment":118},{"nctId":"NCT00391768","phase":"PHASE1, PHASE2","title":"Oseltamivir Treatment for Children Less Than 24 Months of Age With Influenza","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2007-01","conditions":"Influenza","enrollment":87},{"nctId":"NCT01130636","phase":"PHASE4","title":"Observational Study on the Pharmacokinetics of Oseltamivir in the Treatment of Influenza During Lactation","status":"COMPLETED","sponsor":"Pharmahungary Group","startDate":"2010-06","conditions":"Influenza","enrollment":6},{"nctId":"NCT00980109","phase":"PHASE4","title":"Long Term Influenza Prophylaxis With Inhaled Zanamivir or Oral Oseltamivir","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2009-09","conditions":"Influenza","enrollment":390},{"nctId":"NCT00540501","phase":"PHASE1","title":"A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects","status":"WITHDRAWN","sponsor":"GlaxoSmithKline","startDate":"2007-10","conditions":"Healthy Subjects","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":50,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["TAMIFLU®"],"phase":"phase_3","status":"active","brandName":"Oseltamivir IV","genericName":"Oseltamivir IV","companyName":"Hoffmann-La Roche","companyId":"roche","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Oseltamivir is a neuraminidase inhibitor that blocks the release of influenza virus particles from infected cells, reducing viral spread. Used for Treatment of acute influenza infection in hospitalized patients, Prophylaxis of influenza in high-risk patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}